Articles with public access mandates - Bhavisha PatelLearn more
Not available anywhere: 3
Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS
MA Ferrada, KA Sikora, Y Luo, KV Wells, B Patel, EM Groarke, ...
Arthritis & Rheumatology 73 (10), 1886-1895, 2021
Mandates: US National Institutes of Health, European Commission
Immunosuppressive therapy in severe aplastic anemia
BA Patel, DM Townsley, P Scheinberg
Seminars in Hematology 59 (1), 21-29, 2022
Mandates: US National Institutes of Health
Somatic mutations in VEXAS Syndrome and Erdheim-Chester disease: Inflammatory myeloid diseases
PE Alcedo, F Gutierrez-Rodrigues, BA Patel
Seminars in Hematology 59 (3), 156-166, 2022
Mandates: US National Institutes of Health
Available somewhere: 31
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease
DB Beck, MA Ferrada, KA Sikora, AK Ombrello, JC Collins, W Pei, ...
New England Journal of Medicine 383 (27), 2628-2638, 2020
Mandates: US National Institutes of Health, European Commission
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States
AR Mato, M Thompson, JN Allan, DM Brander, JM Pagel, CS Ujjani, ...
Haematologica 103 (9), 1511, 2018
Mandates: US National Institutes of Health
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1
IE Obiorah, BA Patel, EM Groarke, W Wang, M Trick, AK Ombrello, ...
Blood advances 5 (16), 3203-3215, 2021
Mandates: US National Institutes of Health
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis
MA Ferrada, S Savic, DO Cardona, JC Collins, H Alessi, ...
Blood, The Journal of the American Society of Hematology 140 (13), 1496-1506, 2022
Mandates: US National Institutes of Health, Cancer Research UK, Wellcome Trust
Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study
BA Patel, EM Groarke, J Lotter, R Shalhoub, F Gutierrez-Rodrigues, ...
Blood, The Journal of the American Society of Hematology 139 (1), 34-43, 2022
Mandates: US National Institutes of Health
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome
A Vicente, BA Patel, F Gutierrez-Rodrigues, EM Groarke, V Giudice, ...
Haematologica 105 (12), 2785, 2020
Mandates: US National Institutes of Health
Spectrum of clonal hematopoiesis in VEXAS syndrome
F Gutierrez-Rodrigues, Y Kusne, J Fernandez, T Lasho, R Shalhoub, ...
Blood, The Journal of the American Society of Hematology 142 (3), 244-259, 2023
Mandates: Fundação de Amparo à Pesquisa do Estado de São Paulo, US National Institutes …
Eltrombopag added to immunosuppression for children with treatment‐naive severe aplastic anaemia
EM Groarke, BA Patel, F Gutierrez‐Rodrigues, O Rios, J Lotter, D Baldoni, ...
British journal of haematology 192 (3), 605-614, 2021
Mandates: US National Institutes of Health
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag
Y Zaimoku, BA Patel, R Shalhoub, EM Groarke, X Feng, CO Wu, ...
Haematologica 107 (1), 126, 2022
Mandates: US National Institutes of Health
Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity
A Pinto-Fernandez, M Salio, T Partridge, J Chen, G Vere, H Greenwood, ...
British journal of cancer 124 (4), 817-830, 2021
Mandates: Cancer Research UK, UK Engineering and Physical Sciences Research Council …
HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia
Y Zaimoku, BA Patel, SD Adams, R Shalhoub, EM Groarke, AAC Lee, ...
Blood, The Journal of the American Society of Hematology 138 (26), 2799-2809, 2021
Mandates: US National Institutes of Health
Deficit of circulating CD19+CD24hiCD38hi regulatory B cells in severe aplastic anaemia
Y Zaimoku, BA Patel, S Kajigaya, X Feng, L Alemu, D Quinones Raffo, ...
British journal of haematology 190 (4), 610-617, 2020
Mandates: US National Institutes of Health
Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia
EM Groarke, BA Patel, R Shalhoub, F Gutierrez-Rodrigues, P Desai, ...
Leukemia 36 (9), 2328-2337, 2022
Mandates: US National Institutes of Health
Differential diagnosis of bone marrow failure syndromes guided by machine learning
F Gutierrez-Rodrigues, E Munger, X Ma, EM Groarke, Y Tang, BA Patel, ...
Blood, The Journal of the American Society of Hematology 141 (17), 2100-2113, 2023
Mandates: Fundação de Amparo à Pesquisa do Estado de São Paulo, US National Institutes …
Outcomes in pediatric patients with severe aplastic anemia treated with standard immunosuppression and eltrombopag
EM Groarke, BA Patel, C Diamond, F Gutierrez-Rodrigues, A Vicente, ...
Blood 134, 454, 2019
Mandates: US National Institutes of Health
Efficacy of JAK1/2 inhibition in murine immune bone marrow failure
EM Groarke, X Feng, N Aggarwal, AL Manley, Z Wu, S Gao, BA Patel, ...
Blood 141 (1), 72-89, 2023
Mandates: US National Institutes of Health
COVID‐19 infection in patients with severe aplastic anaemia
C Paton, L Mathews, EM Groarke, O Rios, J Lotter, BA Patel, NS Young
British journal of haematology 193 (5), 902, 2021
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program